Annual Operating Expenses
$150.92 M
+$50.09 M+49.68%
December 1, 2024
Summary
- As of February 23, 2025, VKTX annual total operating expenses is $150.92 million, with the most recent change of +$50.09 million (+49.68%) on December 1, 2024.
- During the last 3 years, VKTX annual operating expenses has risen by +$95.24 million (+171.04%).
- VKTX annual operating expenses is now at all-time high.
Performance
VKTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$46.24 M
+$9.68 M+26.49%
December 1, 2024
Summary
- As of February 23, 2025, VKTX quarterly total operating expenses is $46.24 million, with the most recent change of +$9.68 million (+26.49%) on December 1, 2024.
- Over the past year, VKTX quarterly operating expenses has stayed the same.
- VKTX quarterly operating expenses is now at all-time high.
Performance
VKTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
VKTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.7% | 0.0% |
| 3 y3 years | +171.0% | 0.0% |
| 5 y5 years | +361.7% | 0.0% |
VKTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +171.0% | at high | +269.6% |
| 5 y | 5-year | at high | +361.7% | at high | +421.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Viking Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $150.92 M(+49.7%) | $46.24 M(+26.5%) |
| Sep 2024 | - | $36.56 M(+7.3%) |
| Jun 2024 | - | $34.05 M(-0.1%) |
| Mar 2024 | - | $34.07 M(+16.3%) |
| Dec 2023 | $100.83 M(+43.3%) | $29.29 M(+7.4%) |
| Sep 2023 | - | $27.27 M(+14.8%) |
| Jun 2023 | - | $23.74 M(+15.6%) |
| Mar 2023 | - | $20.54 M(+1.3%) |
| Dec 2022 | $70.36 M(+26.4%) | $20.28 M(+25.2%) |
| Sep 2022 | - | $16.20 M(-8.1%) |
| Jun 2022 | - | $17.63 M(+8.5%) |
| Mar 2022 | - | $16.25 M(+29.9%) |
| Dec 2021 | $55.68 M(+30.5%) | $12.51 M(-6.7%) |
| Sep 2021 | - | $13.40 M(-13.8%) |
| Jun 2021 | - | $15.54 M(+9.2%) |
| Mar 2021 | - | $14.23 M(+26.3%) |
| Dec 2020 | $42.66 M(+30.5%) | $11.27 M(+14.5%) |
| Sep 2020 | - | $9.84 M(-7.2%) |
| Jun 2020 | - | $10.61 M(-3.1%) |
| Mar 2020 | - | $10.95 M(+23.4%) |
| Dec 2019 | $32.69 M(+24.9%) | $8.87 M(+19.3%) |
| Sep 2019 | - | $7.44 M(-22.3%) |
| Jun 2019 | - | $9.57 M(+40.6%) |
| Mar 2019 | - | $6.81 M(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $26.16 M(+37.2%) | $7.04 M(-4.8%) |
| Sep 2018 | - | $7.39 M(+6.8%) |
| Jun 2018 | - | $6.92 M(+44.1%) |
| Mar 2018 | - | $4.80 M(+8.5%) |
| Dec 2017 | $19.07 M(+37.7%) | $4.43 M(-5.6%) |
| Sep 2017 | - | $4.69 M(-5.8%) |
| Jun 2017 | - | $4.98 M(+0.3%) |
| Mar 2017 | - | $4.97 M(+32.9%) |
| Dec 2016 | $13.85 M(+15.4%) | $3.74 M(+14.5%) |
| Sep 2016 | - | $3.26 M(-8.8%) |
| Jun 2016 | - | $3.58 M(+9.5%) |
| Mar 2016 | - | $3.27 M(-29.3%) |
| Dec 2015 | $12.00 M(-48.9%) | $4.62 M(+7.7%) |
| Sep 2015 | - | $4.29 M(+63.2%) |
| Jun 2015 | - | $2.63 M(+469.8%) |
| Mar 2015 | - | $461.00 K(+30.4%) |
| Dec 2014 | $23.47 M(>+9900.0%) | $353.60 K(-69.2%) |
| Sep 2014 | - | $1.15 M(-94.7%) |
| Jun 2014 | - | $21.76 M(>+9900.0%) |
| Mar 2014 | - | $209.70 K(+1133.5%) |
| Dec 2013 | $101.10 K | - |
| Jun 2013 | - | $17.00 K(+431.3%) |
| Mar 2013 | - | $3200.00(-97.1%) |
| Dec 2012 | - | $109.60 K |
FAQ
- What is Viking Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Viking Therapeutics?
- What is Viking Therapeutics annual operating expenses year-on-year change?
- What is Viking Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Viking Therapeutics?
- What is Viking Therapeutics quarterly operating expenses year-on-year change?
What is Viking Therapeutics annual total operating expenses?
The current annual operating expenses of VKTX is $150.92 M
What is the all time high annual operating expenses for Viking Therapeutics?
Viking Therapeutics all-time high annual total operating expenses is $150.92 M
What is Viking Therapeutics annual operating expenses year-on-year change?
Over the past year, VKTX annual total operating expenses has changed by +$50.09 M (+49.68%)
What is Viking Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of VKTX is $46.24 M
What is the all time high quarterly operating expenses for Viking Therapeutics?
Viking Therapeutics all-time high quarterly total operating expenses is $46.24 M
What is Viking Therapeutics quarterly operating expenses year-on-year change?
Over the past year, VKTX quarterly total operating expenses has changed by $0.00 (0.00%)